Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06329063
NA

Oral Vasopressin Modulates Neural Responses to Looming Visual Stimuli: An Eye-tracking Study

Sponsor: University of Electronic Science and Technology of China

View on ClinicalTrials.gov

Summary

The main aim of the present study is to investigate the effects of orally administered vasopressin (AVP) on the perception of time-to-collision of threatening and non-threatening stimuli by combining a validated looming fear eye-tracking paradigm with a randomized between-subject placebo-controlled pharmacological trial design.

Official title: Vasopressin Modulates Neural Responses to Looming Visual Stimuli: An Eye-tracking Study

Key Details

Gender

All

Age Range

18 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2024-03-05

Completion Date

2025-07-30

Last Updated

2024-04-11

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Vasopressin

Administration of vasopressin (20 IU) (oral spray)

DRUG

Placebo

Administration of placebo (oral spray)

Locations (1)

University of Electronic Science and Technology of China

Chengdu, Sichuan, China